Dr. Adebunmi Ojulari, MD

Dr. Ojulari practices at Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System.

Dr. Ojulari's NPI, 1538510458, was assigned on June 22, 2016. Dr. Ojulari holds Illinois license 036149510.

Dr. Ojulari's primary practice is Northeast Georgia Medical Center Gainesville, at 743 Spring Street, Gainesville, GA 30501 in Hall County. The practice phone is (770) 535-3553.

Dr. Ojulari's primary practice is Northeast Georgia Medical Center Gainesville in Gainesville, Georgia, part of Northeast Georgia Health System. Dr. Ojulari is also affiliated with HSHS St. Elizabeth's Hospital. The medical group on file is Northeast Georgia Physicians Group Inpatient Neurology. Dmand AI also links Dr. Ojulari to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ojulari practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Ojulari's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Ojulari's licenses on file in 3 states: Illinois, Georgia and Indiana.

CMS data shows 1,142 Medicare services from Dr. Ojulari across 3 procedure codes in 2024, for 233 Medicare patients. Medicare paid $73,718 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 233 Medicare patients who saw Dr. Ojulari in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ojulari's median patient age at 73, with 58% women.

In 2024, Dr. Ojulari wrote 452 Medicare Part D claims for 120 patients. 83% of them were for generic drugs. CMS names the drug for 179 of them, across 11 drugs with 11 or more claims each, at $14,441 in total drug cost. In 2023, CMS named 124 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ojulari for performance year 2024, reported as part of a group. Dr. Ojulari accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Ojulari from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $20.